AzTrials
AzTrials

Eccentric HypertrophyNCT06992271

Comparing Two Eccentric Protocols on Muscle Damage

A study testing Fast Eccentric and Slow Eccentric in people with Eccentric Hypertrophy and Muscle Damage, run by New York Institute of Technology at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study will be to test whether a new way of weight training is more effective than typical weight training. The investigators expect that this new way will cause more exercise-induced muscle damage, which helps people build bigger muscles. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Eccentric Hypertrophy, Muscle Damage
What is being tested?
Fast Eccentric and Slow Eccentric
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteUnited States
Study dates
8 Mar 2023to 1 Jun 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Sixteen young adults (ages 18-35) will be enrolled in this study.
  • In order to be enrolled, they must have completed at least three months of resistance training in the past five years in order to minimize the learning effect and chance of injury.

Who cannot join

  • Since regular resistance training reduces the primary outcomes, muscle damage and soreness, individuals who currently participate in chest press resistance training at least once per week will be excluded.
  • Individuals who have musculoskeletal injuries in the shoulder, elbow or wrist that preclude pain-free resistance training, or who have underlying uncontrolled cardiovascular complications will also be excluded.
  • Women who are pregnant, or may consider becoming pregnant over the subsequent 2 months, will be excluded

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Amerigo Rossi, Ed.D contact

516 686-3884

arossi01@nyit.edu

United States1 site, 1 recruiting
  • NYIT

    Old Westbury, New York, 11568

    Amerigo Rossi, EdD, 516-686-3884, arossi01@nyit.edu

    Recruiting

Other trials in United States

About this study

Official title: A Novel Eccentric Resistance Training Strategy to Maximize Exercise Induced Muscle Damage in Young Adults

The purpose of this study will be to test whether a new way of weight training is more effective than typical weight training. The investigators expect that this new way will cause more exercise-induced muscle damage, which helps people build bigger muscles. Another purpose of this study will be to explore perceptions of how muscle soreness impacts participant activities of daily living.

Read the detailed description

Participants will come to the lab for 3 sessions, plus two email follow-up questionnaires.

Session 1 (45 minutes)

  • Complete a demographic questionnaire
  • Self-assess muscle soreness
  • Walk on the treadmill to warm-up
  • Maximal voluntary contraction on the chest press
  • Two sets of eccentric (lowering) bench press at 75% of max

Session 2 (45 minutes)

  • Walk on the treadmill to warm up
  • Maximal voluntary contraction on the chest press
  • Three sets of 10 eccentric contractions at 75% of max
  • Repeat the maximal voluntary contraction on the chest press

Session 2 Follow-up Rate muscle soreness for each of the three days following Session 2 Answer open-ended questions about perceptions of the muscle soreness

Session 3 (45 minutes) Walk on the treadmill to warm up Maximal voluntary contraction on the chest press Three sets of 10 eccentric contractions at 75% of max Repeat the maximal voluntary contraction on the chest press

Session 3 Follow-up Rate muscle soreness for each of the three days following Session 2 Answer open-ended questions about perceptions of the muscle soreness

Being tested
Fast Eccentric, Slow Eccentric

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fast EccentricBehavioural

    Resistance training done quickly

  • Slow EccentricBehavioural

    Resistance training done slowly

Study groups in NCT06992271
Study groupRoleWhat they receive
Fast EccentricExperimentalParticipants will perform fast eccentric resistance training
Receives: Behavioral: Fast Eccentric
Slow eccentricActive comparatorParticipants will perform slow eccentric resistance training
Receives: Behavioral: Slow Eccentric

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle soreness 1

    Visual analog scale as indirect indicator of muscle damage. Scale of 1-5. Higher score = more soreness

    Measured: 1 day

  2. Muscle soreness 2

    Visual analog scale as indirect indicator of muscle damage. Scale of 1-5. Higher score = more soreness

    Measured: 2 days

  3. Muscle soreness 3

    Visual analog scale as indirect indicator of muscle damage. Scale of 1-5. Higher score = more soreness

    Measured: 3 days

  4. Maximal Voluntary Isometric Contraction Change

    Change in MVIC will be used to indicated muscle damage.

    Measured: pre-intervention, immediately after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 May 2025
  2. Study start8 Mar 2023
  3. Primary completion1 Jun 2025 (estimated)
  4. Study completion1 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
Crossover design with two groups
Masking
None (open label)
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06992271
Sponsor's protocol ID
BHS-1835
Status last verified
Nov 2024
First submitted
9 Mar 2023
Last updated
28 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Fast Eccentric and Slow Eccentric in people with Eccentric Hypertrophy and Muscle Damage, run by New York Institute of Technology at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Amerigo Rossi, Ed.D (516 686-3884, arossi01@nyit.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle soreness 1 (time frame: 1 day). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 May 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in